Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-05-29FDA Approved: PERPHENAZINE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for perphenazine submitted by Sandoz Inc.
-
CLINICAL_TRIALS research · 2008-05-28Clinical Trial Update: Oxygen Therapy in Schizophrenia [Phase 3]
Phase 3 trial update evaluating oxygen therapy for schizophrenia, with the current status of the study unknown.
-
FDA approval · 2008-05-21FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for SEROQUEL XR (quetiapine) from AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2008-05-21Clinical Trial Update: Pregnenolone in the Management of Schizophrenia Patients [Phase 1]
A Phase 1 clinical trial evaluating pregnenolone for the management of schizophrenia has completed, reporting early safety and tolerability …
-
CLINICAL_TRIALS trial_result · 2008-05-21Clinical Trial Update: Switch Study of Existing Atypical Antipsychotics to Bifeprunox [Phase 3]
This update notes the completion of a Phase 3 switch study evaluating transitioning from existing atypical antipsychotics to bifeprunox for …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2008-05-21Clinical Trial Update: Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating guanfacine as an adjunct to atypical antipsychotics for cognitive dysfunction in schizophrenia and schizoa…
-
CLINICAL_TRIALS research · 2008-05-21Clinical Trial Update: ECT Schizophrenia Serotonin Study
Clinical trial update for a schizophrenia study exploring electroconvulsive therapy and serotonin mechanisms. The status of the study is cur…
-
FDA approval · 2008-05-16FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone mesylate) submitted by Viatris Specialty LLC.
-
FDA approval · 2008-05-16FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for GEODON (ziprasidone) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2008-05-16Clinical Trial Update: Digital Voice Analysis in Patients With Schizophrenia
Clinical trial evaluating digital voice analysis in patients with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-15Clinical Trial Update: Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia [Phase 3]
A Phase 3 clinical trial evaluating aripiprazole for acutely relapsed schizophrenia (and schizoaffective disorder) has completed enrollment/…
-
FDA approval · 2008-05-13FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
FDA approved a supplemental application for haloperidol decanoate from Patriot Pharmaceuticals LLC, resulting in labeling changes for this l…
-
CLINICAL_TRIALS trial_result · 2008-05-07Clinical Trial Update: Dopaminergic Neurotransmission in Schizophrenia, Patients at Risk and Healthy Subjects [NA]
A completed clinical trial investigating dopaminergic neurotransmission in schizophrenia, including patients at risk and healthy subjects. T…
-
CLINICAL_TRIALS trial_result · 2008-05-06Clinical Trial Update: Extract of Ginkgo Biloba and Tardive Dyskinesia [Phase 3]
Phase 3 clinical trial evaluating a Ginkgo biloba extract for tardive dyskinesia (in patients with schizophrenia) has completed.
-
FDA approval · 2008-04-28FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Mylan Institutional LLC)
FDA approves a supplemental application for HALOPERIDOL DECANOATE from Mylan Institutional LLC (a long-acting injectable antipsychotic).
-
CLINICAL_TRIALS trial_result · 2008-04-10Clinical Trial Update: Amisulpride in Schizophrenic Patients [Phase 4]
This document reports the completion of a Phase 4 clinical trial of amisulpride for schizophrenia. The sponsor is Sanofi.
-
CLINICAL_TRIALS trial_result · 2008-04-10Clinical Trial Update: SOLIACS: Solian Solution in the Acute Setting [Phase 4]
Phase 4 trial SOLIACS evaluated Solian (amisulpride) solution in the acute setting for schizophrenia. The study, conducted by Sanofi, has co…
-
CLINICAL_TRIALS trial_result · 2008-04-08Clinical Trial Update: Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia [Phase 4]
Phase 4 trial evaluating whether adding psychosocial intervention to antipsychotic therapy improves outcomes for patients with schizophrenia…
-
CLINICAL_TRIALS research · 2008-03-31Clinical Trial Update: PREvent First Episode Relapse (PREFER) [Phase 4]
A Phase 4 clinical trial update for PREvent First Episode Relapse (PREFER) in schizophrenia, with the status currently unknown.
-
CLINICAL_TRIALS research · 2008-03-28Clinical Trial Update: Cognitive Determinants of Psychoeducation and Information in Psychoses [NA]
A clinical trial investigating cognitive determinants of psychoeducation and information delivery in psychoses, sponsored by the German Rese…
-
CLINICAL_TRIALS trial_result · 2008-03-24Clinical Trial Update: Bifeprunox in the Treatment of Schizophrenia [Phase 3]
Phase 3 clinical trial of bifeprunox for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-18Clinical Trial Update: Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis [Phase 2]
A Phase 2 study completed to evaluate cannabidiol as a potential antipsychotic in acute schizophrenia, assessing its efficacy in reducing ps…
-
CLINICAL_TRIALS trial_result · 2008-03-18Clinical Trial Update: Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI) [Phase 4]
Phase 4 trial comparing injectable versus oral naltrexone for alcohol dependence in people with serious mental illness has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-12Clinical Trial Update: Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness [Phase 4]
Phase 4 trial evaluated the safety and efficacy of ziprasidone in pediatric psychotic illnesses, including schizophrenia and affective disor…
-
CLINICAL_TRIALS trial_result · 2008-03-11Clinical Trial Update: β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS
A clinical trial evaluating beta-cell function in subjects with schizophrenia treated with atypical antipsychotic drugs has completed.